Table 3.

Pre and Post intervention values for outcome measures

	Group	Pre		Post		Percent change
		mean	SD	mean	SD	average	Lower 95% CI	Upper 95% CI	Within-group P-value
VO2 peak	CON	23.5	2.3	23.2	3.6	−1.2	−7.9	5.6	ns
ml/kg/min	rST	24.6	5.0	24.8	5.4	0.7	−2.4	3.8	ns
	EX	26.1	4.7	28.6	5.2	9.3 †	4.5	14.2	< 0.001
	EX-rST	24.3	5.1	27.2	6.2	11.8 †	7.0	16.7	< 0.001
VO2 peak	CON	2.3	0.4	2.2	0.5	−1.2	−8.2	5.7	ns
L/min	rST	2.5	0.8	2.5	0.8	0.3	−2.6	3.2	ns
	EX	2.6	0.6	2.7	0.7	7.2 †	2.6	11.8	< 0.01
	EX-rST	2.5	0.7	2.6	0.7	6.9 †	1.9	11.9	<0.01
BMI	CON	34.8	5.3	34.6	4.8	−0.4	−2.1	1.4	ns
	rST	34.9	4.4	34.9	4.1	0.0	−1.3	1.2	ns
	EX	34.9	5.3	34.1	4.9	−2.2 ‡	−3.5	−0.9	< 0.01
	EX-rST	35.0	4.2	33.9	4.4	−3.3 †	−4.7	−1.9	< 0.01
Total Body Fat	CON	45.9	5.9	46.6	6.2	1.6	−0.5	3.8	ns
(%)	rST	45.3	5.8	45.1	6.5	−0.5	−2.8	1.8	ns
	EX	44.9	6.3	43.9	6.2	−2.2	−4.0	−0.4	0.02
	EX-rST	44.4	8.0	43.0	8.0	−3.2 ‡	−6.8	0.4	0.08
Weight	CON	96.3	14.1	95.9	13.1	−0.3	−2.0	1.5	ns
(Kg)	rST	101.2	15.2	101.2	14.7	0.1	−1.1	1.2	ns
	EX	97.7	17.5	95.4	16.5	−2.2 †	−3.4	−1.0	<0.01
	EX-rST	100.1	14.5	96.7	14.3	−3.5 †	−4.8	−2.2	<0.01
Systolic BP	CON	133.8	7.2	127.9	9.5	−4.6	−9.4	0.3	ns
mmHg	rST	127.3	10.4	122.6	11.8	−3.8	−7.4	−0.3	0.04
	EX	124.9	11.0	117.9	8.4	−5.7	−10.9	−0.4	0.04
	EX-rST	122.6	7.9	116.7	8.3	−5.0	−9.8	−0.1	0.04
Diastolic BP	CON	80.1	10.0	78.3	6.3	−1.9	−13.1	9.4	ns
mmHg	rST	82.9	5.3	78.9	6.9	−5.1	−9.6	−0.6	0.03
	EX	78.2	8.4	76.9	8.5	−1.8	−7.4	3.9	ns
	EX-rST	78.8	6.8	75.3	8.3	−4.9	−11.2	1.4	ns
Total	CON	4.2	0.7	4.5	0.8	5.7	−11.7	23.1	ns
Cholesterol	rST	5.0	0.8	4.9	0.6	−1.0	−7.0	5.1	ns
mmol/L	EX	4.4	1.0	4.6	0.7	5.5	−4.7	15.7	ns
	EX-rST	4.6	1.3	4.4	1.0	−2.1	−11.5	7.3	ns
HDL	CON	1.5	0.6	1.7	0.7	8.7	−24.7	42.0	ns
Cholesterol	rST	1.8	0.5	1.7	0.3	−1.2	−12.5	10.1	ns
mmol/L	EX	1.7	0.5	1.7	0.4	0.9	−14.9	16.7	ns
	EX-rST	1.7	0.6	1.6	0.5	−0.8	−22.7	21.1	ns
Triglycerides	CON	1.8	0.7	1.9	1.3	−19.6	−74.8	35.7	ns
mmol/L	rST	1.9	1.4	2.1	1.5	16.9	−1.5	35.2	0.07
	EX	1.7	1.0	1.4	0.9	−30.2*	−55.8	−4.7	0.02
	EX-rST	2.1	1.3	1.7	0.9	−19.7	−43.0	3.8	0.09
C-ISI	CON	2.0	1.4	2.1	1.0	13.6	−18.7	46.0	ns
	rST	2.2	1.2	2.1	0.9	−0.4	−26.2	25.3	ns
	EX	2.4	1.1	2.8	1.6	12.0	−4.6	28.6	ns
	EX-rST	2.0	1.1	2.3	1.1	17.8	2.8	32.8	0.02
Fasting insulin	CON	19.3	10.4	16.5	12.3	−17.4	−54.6	19.7	ns
μIU/mL	rST	23.8	16.2	20.2	14.8	−16.5	−34.2	1.1	<0.1
	EX	18.2	11.3	16.2	9.8	−11.5	−32.8	9.8	ns
	EX-rST	20.7	11.4	17.5	7.1	−10.6	−27.6	6.4	ns
2-hr Insulin	CON	164.9	157.3	151.5	105.2	4.1	−53.5	61.6	ns
μIU/mL	rST	78.1	47.0	86.1	21.1	22.5	−11.5	56.4	ns
	EX	101.4	52.7	72.4	46.8	−44.0*	−92.5	4.6	0.07
	EX-rST	134.6	84.8	104.1	95.6	−36.3*	−62.8	−9.8	<0.01
Insulin AUC	CON	17080.2	13274.8	16302.4	11419.1	0.6	−25.7	26.9	ns
μIU/mL	rST	12073.6	5601.0	12447.9	4591.6	6.3	−17.7	30.2	ns
	EX	12992.5	4468.2	12212.4	4828.9	−8.9	−21.6	3.8	ns
	EX-rST	14987.5	8288.3	12620.7	8197.4	−19.4*	−31.4	−7.3	<0.01
Fasting Glucose	CON	104.2	15.8	98.3	12.1	−5.4	−12.3	1.6	ns
mmol/L	rST	103.7	9.9	104.7	14.1	0.5	−3.7	4.7	ns
	EX	95.9	9.6	97.7	9.7	1.9	−2.4	6.2	ns
	EX-rST	102.0	17.3	102.1	12.2	0.5	−3.6	4.6	ns
2-Hr glucose	CON	149.3	37.9	142.6	31.6	−3.7	−20.7	13.2	ns
mmol/L	rST	117.7	35.7	144.2	41.8	21.6	5.8	37.4	0.01
	EX	121.2	26.2	116.7	20.6	−3.3*	−15.9	9.4	ns
	EX-rST	139.8	44.6	126.0	40.6	−11.3*	−25.1	2.5	0.1
Glucose AUC	CON	19825.3	2803.2	18694.7	2918.6	−6.1	−15.5	3.3	ns
mmol/L	rST	17333.3	3354.3	18704.2	3824.6	7.5	−3.9	18.9	ns
	EX	17092.5	3566.5	16751.3	3071.2	−1.6	−7.5	4.4	ns
	EX-rST	18037.9	4669.2	17452.4	4003.0	−3.1	−11.3	5.0	ns

Note: All values were analyzed on the log scale except VO₂ peak (ml/kg/min and L/min) and body fat (%) EX-rST is exercise and sedentary time reductions (n=16), rST is sedentary time reductions (n=14), EX is exercise only (n=16), CON is control (n=8)

ns indicates p-value is greater than 0.1.

^‡is significantly different than CON at p < 0.05;

^*is significantly different than rST;

^†is significantly different than both CON and rST.